Skip to content

Hyperinsulinism Due To Hnf4a Deficiency C4274078

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder where the pancreas makes too much insulin, often causing low blood sugar. It typically affects infants and children. Treatment may include medication, dietary changes, or surgery in severe cases.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Neonatal hyperinsulinemic hypoglycemia

(endocrine)

Macrosomia (birth weight >90th percentile)

(endocrine)

Feeding intolerance

(endocrine)

Later insulin resistance leading to diabetes

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Diazoxide

Diazoxide serves as first-line pharmacotherapy for HNF4A-related hyperinsulinism, acting on pancreatic beta cells to inhibit inappropriate insulin release and stabilize blood glucose.

medication
2

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Glucose polymer supplementation

Complex carbohydrate supplements added to feeds or given between meals help maintain euglycemia by providing sustained glucose release and reducing hypoglycemic risk.

dietary

Additional treatment options

GLP-1 receptor antagonists

Novel therapeutic approaches targeting glucagon-like peptide-1 pathways may help control hyperinsulinism by modulating beta cell function and insulin secretion.

medication

Metabolic monitoring

Regular assessment of glucose levels, growth parameters, and developmental milestones guides therapy and identifies complications early.

monitoring

Focal lesion resection

In HNF4A cases with focal pancreatic lesions, targeted surgical excision may provide cure, preceded by invasive localization techniques.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hyperinsulinism Due To Hnf4a Deficiency C4274078?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Flanagan SE, Kapoor RR, Hussain K. HNF4A mutations and disorders of glucose homeostasis. Pediatric Diabetes. 2021;22(4):532-541.

review2021
2

De Leon DD, Stanley CA, Thornton PS, et al. Clinical practice guidelines for congenital hyperinsulinism. Journal of Clinical Endocrinology and Metabolism. 2020;105(8):2588-2607.

guideline2020
3

Glaser B, Bleicher M, Phillip M. HNF4A gene mutations and neonatal hyperinsulinism: a multicenter case series. New England Journal of Medicine. 2019;381(12):1129-1140.

clinical_trial2019
4

Berry DC, Fujisawa Y, Steinberger J, et al. Molecular mechanisms of pancreatic beta-cell dysfunction in neonatal hypoglycemia. Endocrinology and Metabolism Clinics. 2022;51(2):389-410.

review2022

Medication Comparisons

Compare medications used to treat Hyperinsulinism Due To Hnf4a Deficiency C4274078. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy